annual working capital:
$603.45M+$84.71M(+16.33%)Summary
- As of today (July 1, 2025), APLS annual working capital is $603.45 million, with the most recent change of +$84.71 million (+16.33%) on December 31, 2024.
- During the last 3 years, APLS annual working capital has fallen by -$88.75 million (-12.82%).
- APLS annual working capital is now -23.50% below its all-time high of $788.87 million, reached on December 31, 2020.
Performance
APLS Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$549.34M-$54.10M(-8.97%)Summary
- As of today (July 1, 2025), APLS quarterly working capital is $549.34 million, with the most recent change of -$54.10 million (-8.97%) on March 31, 2025.
- Over the past year, APLS quarterly working capital has dropped by -$46.80 million (-7.85%).
- APLS quarterly working capital is now -43.90% below its all-time high of $979.21 million, reached on March 31, 2022.
Performance
APLS quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
APLS Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.3% | -7.8% |
| 3 y3 years | -12.8% | -43.9% |
| 5 y5 years | +96.3% | -11.6% |
APLS Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.8% | +16.3% | -34.1% | +5.9% |
| 5 y | 5-year | -23.5% | +96.3% | -43.9% | +44.1% |
| alltime | all time | -23.5% | >+9999.0% | -43.9% | +4932.8% |
APLS Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $549.34M(-9.0%) |
| Dec 2024 | $603.45M(+16.3%) | $603.45M(-6.1%) |
| Sep 2024 | - | $642.64M(-7.0%) |
| Jun 2024 | - | $690.81M(+15.9%) |
| Mar 2024 | - | $596.14M(+14.9%) |
| Dec 2023 | $518.74M(-6.0%) | $518.74M(-15.1%) |
| Sep 2023 | - | $611.14M(-14.9%) |
| Jun 2023 | - | $717.85M(-12.0%) |
| Mar 2023 | - | $815.61M(+47.8%) |
| Dec 2022 | $551.91M(-20.3%) | $551.91M(-23.0%) |
| Sep 2022 | - | $716.49M(-14.0%) |
| Jun 2022 | - | $833.18M(-14.9%) |
| Mar 2022 | - | $979.21M(+41.5%) |
| Dec 2021 | $692.20M(-12.3%) | $692.20M(+81.6%) |
| Sep 2021 | - | $381.19M(-23.4%) |
| Jun 2021 | - | $497.34M(-27.9%) |
| Mar 2021 | - | $689.96M(-12.5%) |
| Dec 2020 | $788.87M | $788.87M(+18.3%) |
| Sep 2020 | - | $667.08M(-16.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $795.84M(+28.0%) |
| Mar 2020 | - | $621.67M(+102.3%) |
| Dec 2019 | $307.34M(+65.8%) | $307.34M(-24.4%) |
| Sep 2019 | - | $406.62M(+49.0%) |
| Jun 2019 | - | $272.82M(-6.0%) |
| Mar 2019 | - | $290.14M(+56.5%) |
| Dec 2018 | $185.41M(+5.7%) | $185.41M(-16.8%) |
| Sep 2018 | - | $222.90M(-13.1%) |
| Jun 2018 | - | $256.45M(+64.6%) |
| Mar 2018 | - | $155.79M(-11.2%) |
| Dec 2017 | $175.46M(+639.4%) | $175.46M(+1350.7%) |
| Sep 2017 | - | $12.10M(-76.0%) |
| Jun 2017 | - | $50.45M(+112.6%) |
| Dec 2016 | $23.73M(-31.9%) | $23.73M(-31.9%) |
| Dec 2015 | $34.84M(+164.7%) | $34.84M(+219.2%) |
| Sep 2015 | - | $10.92M(-29.3%) |
| Jun 2015 | - | $15.44M(+17.3%) |
| Dec 2014 | $13.17M(+191.7%) | $13.17M |
| Dec 2013 | $4.51M | - |
FAQ
- What is Apellis Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual working capital year-on-year change?
- What is Apellis Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly working capital year-on-year change?
What is Apellis Pharmaceuticals annual working capital?
The current annual working capital of APLS is $603.45M
What is the all time high annual working capital for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual working capital is $788.87M
What is Apellis Pharmaceuticals annual working capital year-on-year change?
Over the past year, APLS annual working capital has changed by +$84.71M (+16.33%)
What is Apellis Pharmaceuticals quarterly working capital?
The current quarterly working capital of APLS is $549.34M
What is the all time high quarterly working capital for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly working capital is $979.21M
What is Apellis Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, APLS quarterly working capital has changed by -$46.80M (-7.85%)